Scientists discover a surprising way to quiet the anxious mind (2025)

UCSF neuroscientist Jennifer Mitchell is testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD), which affects roughly 5% of U.S. adults and responds poorly to conventional medications. In clinical trials, a single dose of MM120 significantly outperformed standard treatments by promoting neuroplasticity and easing rigid thought patterns, offering new hope for severe anxiety sufferers.